{"id":129228,"date":"2026-05-12T07:42:00","date_gmt":"2026-05-12T10:42:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/"},"modified":"2026-05-12T07:42:00","modified_gmt":"2026-05-12T10:42:00","slug":"knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/","title":{"rendered":"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York"},"content":{"rendered":"\n<div class=\"xn-content\">\n<span class=\"legendSpanClass\">MONTREAL, Canada<\/span>, <span class=\"legendSpanClass\">12 de maio de 2026<\/span> \/PRNewswire\/ &#8212; Knight Therapeutics Inc. (TSX:  GUD) (&#8220;Knight&#8221;), uma empresa farmac\u00eautica pan-americana (ex-EUA), anunciou hoje que Samira Sakhia, presidente e diretora executiva, participar\u00e1 de um bate-papo na <b>confer\u00eancia RBC Capital Markets Global Healthcare 2026<\/b> na ter\u00e7a-feira, 19 de maio de 2026 \u00e0s 09h00 ET no hotel InterContinental New York Barclay em Nova York.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<a href=\"https:\/\/mma.prnewswire.com\/media\/2977129\/Knight_Therapeutics_Inc__Knight_se_apresentar__na_RBC_Capital_Ma.html\" target=\"_blank\" rel=\"nofollow\">  <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2977129\/Knight_Therapeutics_Inc__Knight_se_apresentar__na_RBC_Capital_Ma.jpg\" title=\"Knight Therapeutics Inc. logo (CNW Group\/Knight Therapeutics Inc.)\" alt=\"Knight Therapeutics Inc. logo (CNW Group\/Knight Therapeutics Inc.)\" \/><\/a>\n <\/p>\n<\/p><\/div>\n<div class=\"wcag-arialevel-4\" style=\"margin-block-start: 1.33em;margin-block-end: 1.33em;margin-inline-start: 0px;margin-inline-end: 0px;font-weight: bold;text-align: left\" role=\"heading\">Sobre a Knight Therapeutics Inc. <\/div>\n<p>A Knight Therapeutics Inc., com sede em Montreal, Canad\u00e1, \u00e9 uma empresa farmac\u00eautica com foco na aquisi\u00e7\u00e3o ou licenciamento e comercializa\u00e7\u00e3o de produtos farmac\u00eauticos para o Canad\u00e1 e a Am\u00e9rica Latina. As subsidi\u00e1rias latino-americanas da Knight operam sob os nomes United Medical, Biotoscana Farma e Laboratorio LKM. As a\u00e7\u00f5es da Knight Therapeutics Inc. s\u00e3o negociadas na TSX sob o s\u00edmbolo GUD. Para obter mais informa\u00e7\u00f5es sobre a Knight Therapeutics Inc., visite o site da empresa em <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=pt&amp;o=4685529-1&amp;h=3089620499&amp;u=https%3A%2F%2Fknighttx.com%2F&amp;a=www.knighttx.com\" target=\"_blank\" rel=\"nofollow\">www.knighttx.com<\/a> ou <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=pt&amp;o=4685529-1&amp;h=186035380&amp;u=https%3A%2F%2Fwww.sedarplus.ca%2Flandingpage%2F&amp;a=www.sedarplus.ca\" target=\"_blank\" rel=\"nofollow\">www.sedarplus.ca<\/a>.<\/p>\n<div class=\"wcag-arialevel-4\" style=\"margin-block-start: 1.33em;margin-block-end: 1.33em;margin-inline-start: 0px;margin-inline-end: 0px;font-weight: bold;text-align: left\" role=\"heading\">Declara\u00e7\u00e3o de vis\u00e3o<\/div>\n<p>Este documento cont\u00e9m declara\u00e7\u00f5es relativas ao futuro em rela\u00e7\u00e3o a Knight Therapeutics Inc. e suas subsidi\u00e1rias. Essas declara\u00e7\u00f5es relativas ao futuro, por sua natureza, envolvem necessariamente riscos e incertezas que podem fazer com que os resultados reais sejam materialmente diferentes daqueles contemplados nas declara\u00e7\u00f5es prospectivas. A Knight Therapeutics Inc. considera as suposi\u00e7\u00f5es nas quais essas declara\u00e7\u00f5es relativas ao futuro se baseiam como razo\u00e1veis no momento em que foram preparadas, mas adverte o leitor de que essas suposi\u00e7\u00f5es sobre eventos futuros, muitos dos quais est\u00e3o al\u00e9m do controle da Knight Therapeutics Inc. e de suas subsidi\u00e1rias, podem acabar sendo incorretas. Fatores e riscos que podem fazer com que os resultados reais difiram materialmente das expectativas atuais s\u00e3o discutidos no Relat\u00f3rio Anual da Knight Therapeutics Inc. e no Formul\u00e1rio de Informa\u00e7\u00f5es Anuais da Knight Therapeutics Inc. para o ano encerrado em 31 de dezembro de 2025, arquivado em <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=pt&amp;o=4685529-1&amp;h=186035380&amp;u=https%3A%2F%2Fwww.sedarplus.ca%2Flandingpage%2F&amp;a=www.sedarplus.ca\" target=\"_blank\" rel=\"nofollow\">www.sedarplus.ca<\/a>. A Knight Therapeutics Inc. nega qualquer inten\u00e7\u00e3o ou obriga\u00e7\u00e3o de atualizar ou revisar quaisquer declara\u00e7\u00f5es relativas ao futuro devido a novas informa\u00e7\u00f5es ou eventos futuros, exceto conforme seja exigido por lei.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"> <\/span><\/p>\n<p class=\"prnml4\"><span class=\"prnews_span\"><b>Contato de investidores:<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Knight Therapeutics Inc.<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"> <\/span><\/p>\n<p class=\"prnml4\"><span class=\"prnews_span\">Samira Sakhia<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"> <\/span><\/p>\n<p class=\"prnml4\"><span class=\"prnews_span\">Arvind Utchanah<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Presidente e Diretora Executiva<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Diretor Financeiro<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Tel.: 514.484.4483 <\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Tel.: 598.2626.2344 <\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">F: 514.481.4116<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Email: <a href=\"mailto:IR@knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">IR@knighttx.com<\/a><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Email: <a href=\"mailto:IR@knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">IR@knighttx.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Website: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=pt&amp;o=4685529-1&amp;h=3089620499&amp;u=https%3A%2F%2Fknighttx.com%2F&amp;a=www.knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">www.knighttx.com<\/a><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Website: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=pt&amp;o=4685529-1&amp;h=3089620499&amp;u=https%3A%2F%2Fknighttx.com%2F&amp;a=www.knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">www.knighttx.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Logo &#8211; <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=pt&amp;o=4685529-1&amp;h=504512856&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2977129%2Flogos_todos.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2977129%2Flogos_todos.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/2977129\/logos_todos.jpg<\/a><\/p>\n<p id=\"PURL\"><img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=PT56291&amp;sd=2026-05-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/br\/comunicados-para-a-imprensa\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york-302768529.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/br\/comunicados-para-a-imprensa\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york-302768529.html<\/a><\/p>\n<p>FONTE Knight Therapeutics Inc.<\/p>\n<\/div>\n<p>  <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PT56291&amp;Transmission_Id=202605120635PR_NEWS_LATAM____PT56291&amp;DateId=20260512\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n<p><strong>T\u00f3picos Relacionados:<\/strong> Produtos Farmac\u00eauticos, M\u00e9dico \/ Farmac\u00eautico, Not\u00edcias de Feiras Comerciais, Sa\u00fade\/Hospitais<\/p>\n<p>A <b>OESP<\/b> n\u00e3o \u00e9(s\u00e3o) respons\u00e1vel(is) por erros, incorre\u00e7\u00f5es, atrasos ou quaisquer decis\u00f5es tomadas por seus clientes com base nos Conte\u00fados ora disponibilizados, bem como tais Conte\u00fados n\u00e3o representam a opini\u00e3o da <b>OESP<\/b> e s\u00e3o de inteira responsabilidade da <b>PR Newswire Ltda<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"MONTREAL, Canada, 12 de maio de 2026 \/PRNewswire\/ &#8212; Knight Therapeutics Inc. (TSX: GUD) (&#8220;Knight&#8221;), uma empresa farmac\u00eautica pan-americana (ex-EUA), anunciou hoje que Samira Sakhia,","protected":false},"author":1,"featured_media":129229,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[27],"tags":[9609,9607,9611,9610,9608],"class_list":["post-129228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-prnewswire","tag-anunciou-hoje-que-samira-sakhia","tag-knight-therapeutics-inc-tsx-gud-knight","tag-participara-de","tag-presidente-e-diretora-executiva","tag-uma-empresa-farmaceutica-pan-americana-ex-eua"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"og:description\" content=\"MONTREAL, Canada, 12 de maio de 2026 \/PRNewswire\/ &#8212; Knight Therapeutics Inc. (TSX: GUD) (&#8220;Knight&#8221;), uma empresa farmac\u00eautica pan-americana (ex-EUA), anunciou hoje que Samira Sakhia,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/\" \/>\n<meta property=\"og:site_name\" content=\"Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-12T10:42:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-12_10.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"patric_oliveira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"patric_oliveira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/\"},\"author\":{\"name\":\"patric_oliveira\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"headline\":\"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York\",\"datePublished\":\"2026-05-12T10:42:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/\"},\"wordCount\":506,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-12_10.jpg\",\"keywords\":[\"anunciou hoje que Samira Sakhia\",\"Knight Therapeutics Inc. (TSX: GUD) (\\\"Knight\\\")\",\"participar\u00e1 de\",\"presidente e diretora executiva\",\"uma empresa farmac\u00eautica pan-americana (ex-EUA)\"],\"articleSection\":[\"PR Newswire\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/\",\"name\":\"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-12_10.jpg\",\"datePublished\":\"2026-05-12T10:42:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-12_10.jpg\",\"contentUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/1_53_2_2026-05-12_10.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\",\"name\":\"Ag\u00eancia de Comunica\u00e7\u00e3o\",\"description\":\"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\",\"name\":\"patric_oliveira\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"caption\":\"patric_oliveira\"},\"sameAs\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"],\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/author\\\/patric_oliveira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/","og_locale":"pt_BR","og_type":"article","og_title":"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o","og_description":"MONTREAL, Canada, 12 de maio de 2026 \/PRNewswire\/ &#8212; Knight Therapeutics Inc. (TSX: GUD) (&#8220;Knight&#8221;), uma empresa farmac\u00eautica pan-americana (ex-EUA), anunciou hoje que Samira Sakhia,","og_url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/","og_site_name":"Ag\u00eancia de Comunica\u00e7\u00e3o","article_published_time":"2026-05-12T10:42:00+00:00","og_image":[{"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-12_10.jpg","width":1,"height":1,"type":"image\/jpeg"}],"author":"patric_oliveira","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"patric_oliveira","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#article","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/"},"author":{"name":"patric_oliveira","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"headline":"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York","datePublished":"2026-05-12T10:42:00+00:00","mainEntityOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/"},"wordCount":506,"commentCount":0,"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#primaryimage"},"thumbnailUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-12_10.jpg","keywords":["anunciou hoje que Samira Sakhia","Knight Therapeutics Inc. (TSX: GUD) (\"Knight\")","participar\u00e1 de","presidente e diretora executiva","uma empresa farmac\u00eautica pan-americana (ex-EUA)"],"articleSection":["PR Newswire"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/","name":"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York - Ag\u00eancia de Comunica\u00e7\u00e3o","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#primaryimage"},"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#primaryimage"},"thumbnailUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-12_10.jpg","datePublished":"2026-05-12T10:42:00+00:00","author":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"breadcrumb":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#primaryimage","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-12_10.jpg","contentUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2026\/05\/1_53_2_2026-05-12_10.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/knight-se-apresentara-na-rbc-capital-markets-global-healthcare-conference-2026-em-nova-york\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"},{"@type":"ListItem","position":2,"name":"Knight se apresentar\u00e1 na RBC Capital Markets Global Healthcare Conference 2026 em Nova York"}]},{"@type":"WebSite","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/","name":"Ag\u00eancia de Comunica\u00e7\u00e3o","description":"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37","name":"patric_oliveira","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","caption":"patric_oliveira"},"sameAs":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"],"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/author\/patric_oliveira\/"}]}},"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/129228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=129228"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/129228\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media\/129229"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=129228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=129228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=129228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}